The role of costs in comparative effectiveness research

DSpace/Manakin Repository

The role of costs in comparative effectiveness research

Citable link to this page

 

 
Title: The role of costs in comparative effectiveness research
Author: Garber, Alan M; Sox, Harold C.

Note: Order does not necessarily reflect citation order of authors.

Citation: Garber, Alan M., and Harold C. Sox. 2010. The role of costs in comparative effectiveness research. Health Affairs 29, 10:1805-1811.
Access Status: Full text of the requested work is not available in DASH at this time (“dark deposit”). For more information on dark deposits, see our FAQ.
Full Text & Related Files:
Abstract: The major expansion of federal comparative effectiveness research launched in 2009 held the potential to supply the information needed to help slow health spending growth while improving the outcomes of care. However, when Congress passed the Patient Protection and Affordable Care Act one year later, it limited the role of cost analysis in the work sponsored by the Patient-Centered Outcomes Research Institute. Despite this restriction, cost-effectiveness analysis meets important needs and is likely to play a larger role in the future. Under the terms of the Affordable Care Act, the institute can avoid commissioning cost-effectiveness analyses and still provide information bearing on the use and costs of health care interventions. This information will enable others to investigate the comparative value of these interventions. We argue that doing so is necessary to decision makers who are attempting to raise the quality of care while reining in health spending.
Published Version: 10.1377/hlthaff.2010.0647
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:11577899
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters